Atlas Venture Life Science Advisors, LLC Top Holdings and 13F Report (2023)

About Atlas Venture Life Science Advisors, LLC

Investment Activity

  • Atlas Venture Life Science Advisors, LLC has $631.19 million in total holdings as of March 31, 2023.
  • Atlas Venture Life Science Advisors, LLC owns shares of 9 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
  • Approximately 9.80% of the portfolio was purchased this quarter.
  • About 10.22% of the portfolio was sold this quarter.
  • This quarter, Atlas Venture Life Science Advisors, LLC has purchased 7 new stocks and bought additional shares in 0 stocks.
  • Atlas Venture Life Science Advisors, LLC sold shares of 3 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

Kymera Therapeutics
$318,326,608
Disc Medicine
$90,598,277
Obsidian Therapeutics, Inc.
$61,828,236
Kailera Therapeutics, Inc.
$59,056,040
Dyne Therapeutics, Inc.
$55,429,999

Largest New Holdings this Quarter

67448A106 - Obsidian Therapeutics, Inc.
$61,828,236 Holding
67613T104 - Odyssey Therapeutics, Inc.
$59,816 Holding

Largest Purchases this Quarter

Obsidian Therapeutics, Inc.
4,503,149 shares (about $61.83M)
Odyssey Therapeutics, Inc.
2,692 shares (about $59.82K)

Largest Sales this Quarter

Dyne Therapeutics, Inc.
3,359,379 shares (about $54.12M)
Disc Medicine
129,850 shares (about $8.50M)
Korro Bio, Inc.
189,624 shares (about $1.88M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofAtlas Venture Life Science Advisors, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$318,326,6080.0%2,847,54150.4%Healthcare
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$90,598,277$8,499,981 ▼-8.6%1,384,02514.4%Healthcare
Obsidian Therapeutics, Inc.
$61,828,236$61,828,236 ▲New Holding4,503,1499.8%Common Stock
Kailera Therapeutics, Inc.
$59,056,0400.0%5,171,2829.4%Common Stock
Dyne Therapeutics, Inc.
$55,429,999$54,119,595 ▼-49.4%3,440,7208.8%Common Stock
Q32 Bio, Inc.
$22,470,4670.0%2,717,1063.6%Common Stock
Sionna Therapeutics, Inc.
$15,756,8670.0%2,995,6022.5%Common Stock
Korro Bio, Inc.
$7,663,007$1,879,174 ▼-19.7%773,2601.2%Common Stock
Odyssey Therapeutics, Inc.
$59,816$59,816 ▲New Holding2,6920.0%Common Stock

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data